Aura Biosciences insider sale notice

Aura Biosciences submitted a Form 144 notice relating to Common Stock transactions through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

Aura Biosciences submitted a Form 144 notice relating to Common Stock transactions through Morgan Stanley Smith Barney LLC. The filing records a sale of $92,734.66 for 17,109 shares on 11/17/2025 by Janet Jill Hopkins. The filing also lists restricted stock unit awards of 7,129 (granted 02/01/2024) and 30,159 (granted 02/03/2025) described as subject to vesting requirements.

Insights

Securities Compliance Counsel

Form 144 reports a recent director/insider sale and lists outstanding restricted stock units.

The filing records a sale of 17,109 shares for $92,734.66 on 11/17/2025, with Morgan Stanley Smith Barney LLC named as the broker. It also lists RSU awards of 7,129 and 30,159 described as subject to vesting.

These items are routine disclosures under resale rules. Timing and broader proceeds treatment beyond the broker and the single sale are not detailed in the excerpt; subsequent filings would show further activity if it occurs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aura Biosciences' Form 144 disclose about insider sales?

The Form 144 discloses a sale of 17,109 shares by Janet Jill Hopkins for $92,734.66 on 11/17/2025. The filing names Morgan Stanley Smith Barney LLC as the broker handling the transaction.

Does the filing show any restricted stock units for Aura (AURA)?

Yes. The filing lists restricted stock unit awards of 7,129 granted on 02/01/2024 and 30,159 granted on 02/03/2025, each described as subject to vesting requirements under the 2021 plan.

Who acted as broker for the reported sale in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC, with an address shown in Sandy, Utah. The broker is listed in connection with the Common Stock transaction reported on the form.

Is the reported sale a recent transaction for Aura insiders?

Yes. The excerpt shows a sale dated 11/17/2025 of 17,109 shares for $92,734.66 by Janet Jill Hopkins, reported in the Form 144 filing.

Do the RSU entries in the Form 144 indicate they were sold?

No. The entries identify the awards as restricted stock unit awards granted on 02/01/2024 and 02/03/2025 and state they are subject to vesting requirements; the entries do not state they were sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:50 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001997710
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aura Biosciences, Inc.
SEC File Number	001-40971
Address of Issuer	80 Guest Street Boston MASSACHUSETTS 02135
Phone	617-500-8864
Name of Person for Whose Account the Securities are To Be Sold	Hopkins Janet Jill
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Drive 200 West Civic Center 4th Floor Sandy UT 84070	20401	103231.16	63503269	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/01/2024	Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.	Aura Biosciences, Inc.			7129	02/01/2024	N/A
Common Stock	02/03/2025	Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.	Aura Biosciences, Inc.			30159	02/03/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Janet Jill Hopkins 80 Guest Street Boston MA 02135	Common Stock	11/17/2025	17109	92734.66

144: Remarks and Signature

Remarks	The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Amy Elazzouzi, as Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)